2025-12-5 10.1.6.65
Code of China Chinese Classification Professional Classification ICS Classification Latest News Value-added Services

Position: Chinese Standard in English/GB/T 16886.2-2011
GB/T 16886.2-2011   Biological evaluation of medical devices—Part 2:Animal welfare requirements (English Version)
Standard No.: GB/T 16886.2-2011 Status:valid remind me the status change

Email:

Target Language:English File Format:PDF
Word Count: 7000 words Translation Price(USD):140.0 remind me the price change

Email:

Implemented on:2012-5-1 Delivery: via email in 1 business day

→ → →

,,2012-5-1,141138181895723D9741B6902C209
Standard No.: GB/T 16886.2-2011
English Name: Biological evaluation of medical devices—Part 2:Animal welfare requirements
Chinese Name: 医疗器械生物学评价 第2部分:动物福利要求
Chinese Classification: C30    Medical apparatus and devices in general
Professional Classification: GB    National Standard
ICS Classification: 11.040.01 11.040.01    Medical equipment in general 11.040.01
Source Content Issued by: AQSIQ;SAC
Issued on: 2011-12-30
Implemented on: 2012-5-1
Status: valid
Superseding:GB/T 16886.2-2000 Biological evaluation of medical devices--Part 2:Animal welfare requirements
Target Language: English
File Format: PDF
Word Count: 7000 words
Translation Price(USD): 140.0
Delivery: via email in 1 business day
GB/T 16886.2-2011 Biological evaluation of medical devices - Part 2: Animal welfare requirements 1 Scope This part of GB/T 16886 is aimed at those who commission, design and perform tests or evaluate data from animal tests undertaken to assess the biocompatibility of materials intended for use in medical devices, or that of the medical devices themselves. It specifies the minimum requirements to be satisfied to ensure and demonstrate that proper provision has been made for the welfare of animals used in animal tests to assess the biocompatibility of materials used in medical devices. It also makes recommendations and offers guidance intended to facilitate future further reductions in the overall number of animals used, refinement of test methods to reduce or eliminate pain or distress in animals, and the replacement of animal tests by other scientifically valid means not requiring animal tests. It applies to tests performed on living vertebrate animals, other than man, to establish the biocompatibility of materials or medical devices. It does not apply to tests performed on invertebrate animals and other lower forms; nor (other than with respect to provisions relating to species, source, health status, and care and accommodation) does it apply to testing performed on isolated tissues and organs taken from vertebrate animals that have been euthanized. 2 Normative references The following referenced documents are indispensable for the application of this document. For dated references, only the edition cited applies. For undated references, the latest edition of the referenced document (including any amendments) applies. ISO 10993-1 Biological evaluation of medical devices - Part 1: Evaluation and testing with in a risk management process 3 Terms and definitions For the purposes of this document, the terms and definitions given in ISO 10993-1 and the following apply. 3.1 alternative method any test method that replaces an animal test, reduces the numbers of animals used, or refines the procedures applied 3.2 animal any live non-human vertebrate, excluding immature forms during the first half of gestation of incubation 3.3 animal test any use of an animal for scientific purposes Note 1: The definition of an animal test excludes acts of recognized veterinary practice applied for the benefit of an animal or the group of animals of which it is part; recognized husbandry practices to manage or conserve the animal or the group of which it is part; marking by methods which cause no more than momentary pain or distress; and euthanasia. Note 2: The prevention of pain, suffering, distress or lasting harm by the effective use of anaesthesia or analgesia or other methods of rendering the animal insentient to pain (e.g. decerebration) does not place animal tests outside the scope of this definition. The administration of anaesthetics, analgesics or other methods of rendering the animal insentient to pain are considered to constitute an integral part of the animal test. 3.4 competent authority body designated or recognized by a national government to take responsibility for overseeing, supervising or regulating animal tests, or the breeding and supply of purpose-bred animals for use on such tests, within the scope of this part of GB/T 16886 3.5 euthanasia humane killing of an animal by a method causing a minimum of physical and mental suffering 3.6 humane endpoints pre-determined, specific criteria and measures to be implemented to minimize or terminate pain, suffering or distress caused by animal tests as soon as the scientific objectives have been met, or when it is realized they cannot be met, or when the animal welfare problems being encountered are greater than can be justified by the importance, potential benefits, objectives and nature of the study 3.7 procedural training prior training and acclimatizing of animals to the interventions to be performed during an animal test, with a view to minimizing stress to the animal when animal tests are conducted 3.8 protocol documentation prepared in advance of animal tests being undertaken setting out the justification, rationale and test method (including scientific and humane endpoints) for the animal tests 3.9 purpose-bred animal any animal bred with the intention that it be used in animal tests or for other experimental or scientific purposes 3.10 reduction reducing to the essential minimum the number of animals used in an animal test to meet a defined scientific objective 3.11 refinement sum total of measures taken to safeguard the welfare of the test animals by minimizing any resulting pain, suffering, distress or lasting harm to the animals that are used 3.12 replacement any scientifically valid and reasonably and practically available test method that either completely or partially replaces the use of living vertebrate animals with test methods that have not the potential to cause pain or distress to animals 3.13 test animal any animal used in in vivo animal tests, or used to provide tissue for ex vivo or in vitro tests 3.14 validation formal process by which the reliability and relevance of a test method is established for a particular purpose 4 Requirements 4.1 General This part of ISO 10993 sets forth essential requirements when animal tests are being considered, planned or performed for the biological evaluation of materials used in medical devices. It has been developed to protect the welfare of animals used in the biological evaluation of materials used in medical devices without compromising, indeed to help to ensure, the scientific validity of the test results and the risk assessments that shall subsequently be performed. This part focuses on the need to demonstrate that animal welfare is properly considered when expert judgement has to be exercised in relation to the biological evaluation of medical device materials, and that the principles of humane experimental technique are demonstrably applied to the design and conduct of animal tests. This part requires that the need to perform animal tests is justified, and any pain, suffering, distress or lasting harm that is caused during essential animal tests is minimized. This part sets out essential requirements that safeguard animal welfare by minimizing the pain and distress caused when animal tests are considered or undertaken by: a) establishing a framework that reflects the relevant ethical and, in many jurisdictions, the legal considerations relating to the use of animals for experimental or other scientific purposes; b) minimizing the number of animal tests by the appropriate use of literature searches, data-sharing, validated replacement alternatives, and appropriate testing strategies and study designs; c) minimizing any pain, suffering, distress and lasting harm caused to animals used in tests to evaluate the biocompatibility of materials used in medical devices by requiring appropriate use of relevant reduction and refinement alternatives;
Contents Foreword i Introduction iii 1 Scope 2 Normative references 3 Terms and definitions 4 Requirements Annex A (Informative) Rationale for the development of this part Annex B (Informative) Further suggestions for replacing, reducing and refining animal tests Bibliography
GB/T 16886.2-2011 is referred in:
*GB/T 16886.3-2008 Biological evaluation of medical devices - Part 3: Tests for genotoxicity carcinogenicity and reproductive toxicity
*YY 0861-2011 Ophthalmic optics—Ophthalmic viscosurgical devices
*YY/T 1754.1-2020 Preclinical animal study of medical devices—Part 1:General considerations
*YY/T 1754.2-2020 Preclinical animal study of medical devices—Part 2:Model of skin defect in induced diabetic rats
*GB/T 16886.10-2005 Biological evaluation of medical devices-Part 10:Tests for irritation and delayed-type hypersensitivity
*GB/T 16886.1-2022 Biological evaluation of medical devices—Part 1: Evaluation and testing within a risk management process
*GB/T 16886.3-2019 Biological evaluation of medical devices—Part 3:Tests for genotoxicity, carcinogenicity and reproductive toxicity
Code of China
Standard
GB/T 16886.2-2011  Biological evaluation of medical devices—Part 2:Animal welfare requirements (English Version)
Standard No.GB/T 16886.2-2011
Statusvalid
LanguageEnglish
File FormatPDF
Word Count7000 words
Price(USD)140.0
Implemented on2012-5-1
Deliveryvia email in 1 business day
Detail of GB/T 16886.2-2011
Standard No.
GB/T 16886.2-2011
English Name
Biological evaluation of medical devices—Part 2:Animal welfare requirements
Chinese Name
医疗器械生物学评价 第2部分:动物福利要求
Chinese Classification
C30
Professional Classification
GB
ICS Classification
Issued by
AQSIQ;SAC
Issued on
2011-12-30
Implemented on
2012-5-1
Status
valid
Superseded by
Superseded on
Abolished on
Superseding
GB/T 16886.2-2000 Biological evaluation of medical devices--Part 2:Animal welfare requirements
Language
English
File Format
PDF
Word Count
7000 words
Price(USD)
140.0
Keywords
GB/T 16886.2-2011, GB 16886.2-2011, GBT 16886.2-2011, GB/T16886.2-2011, GB/T 16886.2, GB/T16886.2, GB16886.2-2011, GB 16886.2, GB16886.2, GBT16886.2-2011, GBT 16886.2, GBT16886.2
Introduction of GB/T 16886.2-2011
GB/T 16886.2-2011 Biological evaluation of medical devices - Part 2: Animal welfare requirements 1 Scope This part of GB/T 16886 is aimed at those who commission, design and perform tests or evaluate data from animal tests undertaken to assess the biocompatibility of materials intended for use in medical devices, or that of the medical devices themselves. It specifies the minimum requirements to be satisfied to ensure and demonstrate that proper provision has been made for the welfare of animals used in animal tests to assess the biocompatibility of materials used in medical devices. It also makes recommendations and offers guidance intended to facilitate future further reductions in the overall number of animals used, refinement of test methods to reduce or eliminate pain or distress in animals, and the replacement of animal tests by other scientifically valid means not requiring animal tests. It applies to tests performed on living vertebrate animals, other than man, to establish the biocompatibility of materials or medical devices. It does not apply to tests performed on invertebrate animals and other lower forms; nor (other than with respect to provisions relating to species, source, health status, and care and accommodation) does it apply to testing performed on isolated tissues and organs taken from vertebrate animals that have been euthanized. 2 Normative references The following referenced documents are indispensable for the application of this document. For dated references, only the edition cited applies. For undated references, the latest edition of the referenced document (including any amendments) applies. ISO 10993-1 Biological evaluation of medical devices - Part 1: Evaluation and testing with in a risk management process 3 Terms and definitions For the purposes of this document, the terms and definitions given in ISO 10993-1 and the following apply. 3.1 alternative method any test method that replaces an animal test, reduces the numbers of animals used, or refines the procedures applied 3.2 animal any live non-human vertebrate, excluding immature forms during the first half of gestation of incubation 3.3 animal test any use of an animal for scientific purposes Note 1: The definition of an animal test excludes acts of recognized veterinary practice applied for the benefit of an animal or the group of animals of which it is part; recognized husbandry practices to manage or conserve the animal or the group of which it is part; marking by methods which cause no more than momentary pain or distress; and euthanasia. Note 2: The prevention of pain, suffering, distress or lasting harm by the effective use of anaesthesia or analgesia or other methods of rendering the animal insentient to pain (e.g. decerebration) does not place animal tests outside the scope of this definition. The administration of anaesthetics, analgesics or other methods of rendering the animal insentient to pain are considered to constitute an integral part of the animal test. 3.4 competent authority body designated or recognized by a national government to take responsibility for overseeing, supervising or regulating animal tests, or the breeding and supply of purpose-bred animals for use on such tests, within the scope of this part of GB/T 16886 3.5 euthanasia humane killing of an animal by a method causing a minimum of physical and mental suffering 3.6 humane endpoints pre-determined, specific criteria and measures to be implemented to minimize or terminate pain, suffering or distress caused by animal tests as soon as the scientific objectives have been met, or when it is realized they cannot be met, or when the animal welfare problems being encountered are greater than can be justified by the importance, potential benefits, objectives and nature of the study 3.7 procedural training prior training and acclimatizing of animals to the interventions to be performed during an animal test, with a view to minimizing stress to the animal when animal tests are conducted 3.8 protocol documentation prepared in advance of animal tests being undertaken setting out the justification, rationale and test method (including scientific and humane endpoints) for the animal tests 3.9 purpose-bred animal any animal bred with the intention that it be used in animal tests or for other experimental or scientific purposes 3.10 reduction reducing to the essential minimum the number of animals used in an animal test to meet a defined scientific objective 3.11 refinement sum total of measures taken to safeguard the welfare of the test animals by minimizing any resulting pain, suffering, distress or lasting harm to the animals that are used 3.12 replacement any scientifically valid and reasonably and practically available test method that either completely or partially replaces the use of living vertebrate animals with test methods that have not the potential to cause pain or distress to animals 3.13 test animal any animal used in in vivo animal tests, or used to provide tissue for ex vivo or in vitro tests 3.14 validation formal process by which the reliability and relevance of a test method is established for a particular purpose 4 Requirements 4.1 General This part of ISO 10993 sets forth essential requirements when animal tests are being considered, planned or performed for the biological evaluation of materials used in medical devices. It has been developed to protect the welfare of animals used in the biological evaluation of materials used in medical devices without compromising, indeed to help to ensure, the scientific validity of the test results and the risk assessments that shall subsequently be performed. This part focuses on the need to demonstrate that animal welfare is properly considered when expert judgement has to be exercised in relation to the biological evaluation of medical device materials, and that the principles of humane experimental technique are demonstrably applied to the design and conduct of animal tests. This part requires that the need to perform animal tests is justified, and any pain, suffering, distress or lasting harm that is caused during essential animal tests is minimized. This part sets out essential requirements that safeguard animal welfare by minimizing the pain and distress caused when animal tests are considered or undertaken by: a) establishing a framework that reflects the relevant ethical and, in many jurisdictions, the legal considerations relating to the use of animals for experimental or other scientific purposes; b) minimizing the number of animal tests by the appropriate use of literature searches, data-sharing, validated replacement alternatives, and appropriate testing strategies and study designs; c) minimizing any pain, suffering, distress and lasting harm caused to animals used in tests to evaluate the biocompatibility of materials used in medical devices by requiring appropriate use of relevant reduction and refinement alternatives;
Contents of GB/T 16886.2-2011
Contents Foreword i Introduction iii 1 Scope 2 Normative references 3 Terms and definitions 4 Requirements Annex A (Informative) Rationale for the development of this part Annex B (Informative) Further suggestions for replacing, reducing and refining animal tests Bibliography
About Us   |    Contact Us   |    Terms of Service   |    Privacy   |    Cancellation & Refund Policy   |    Payment
Tel: +86-10-8572 5655 | Fax: +86-10-8581 9515 | Email: coc@codeofchina.com | QQ: 672269886
Copyright: Beijing COC Tech Co., Ltd. 2008-2040
 
 
Keywords:
GB/T 16886.2-2011, GB 16886.2-2011, GBT 16886.2-2011, GB/T16886.2-2011, GB/T 16886.2, GB/T16886.2, GB16886.2-2011, GB 16886.2, GB16886.2, GBT16886.2-2011, GBT 16886.2, GBT16886.2